MacKenzie Iain
Known title: DirectorCIK: 0001344017
MacKenzie Iain's purchase track record
How the stock did after each of MacKenzie Iain's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since August 7, 2025
Stock higher 6 months later
100%
3 months: 67%
Median 6-month return
+366.1%
3 months: +89.0%
Beat the S&P 500
100%
median +355.1% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/17/2025 | ICHR | $145K | +229.4% | +366.1% | +10.9% |
| 11/6/2025 | ICHR | $153K | +89.0% | +372.0% | +9.2% |
| 8/7/2025 | ICHR | $416K | -9.4% | +71.2% | +7.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ICHR | ▼ Sell | Open Market | 17,400 | $879K | 9/15/2026 | View on chart |
| ICHR | ▼ Sell | Open Market | 2,600 | $134K | 9/15/2026 | View on chart |
| ICHR | ▼ Sell | Open Market | 3,150 | $208K | 8/18/2026 | View on chart |
| ICHR | ▼ Sell | Open Market | 5,183 | $338K | 8/18/2026 | View on chart |
| ICHR | ▼ Sell | Open Market | 1,200 | $80K | 8/18/2026 | View on chart |
| ICHR | ▼ Sell | Open Market | 400 | $27K | 8/18/2026 | View on chart |
| ICHR | ▲ Buy | Grant | 2,349 | $0 | 5/14/2026 | View on chart |
| ICHR | ▲ Buy | Open Market | 10,000 | $145K | 11/17/2025 | View on chart |
| ICHR | ▲ Buy | Open Market | 10,000 | $153K | 11/6/2025 | View on chart |
| ICHR | ▲ Buy | Grant | 50,000 | $0 | 9/15/2025 | View on chart |
| ICHR | ▲ Buy | Open Market | 25,000 | $416K | 8/7/2025 | View on chart |
| ICHR | ▲ Buy | Grant | 5,337 | $0 | 5/14/2025 | View on chart |
| ICHR | ▲ Buy | Grant | 3,923 | $0 | 5/15/2024 | View on chart |
| ICHR | ▲ Buy | Grant | 4,752 | $0 | 5/18/2023 | View on chart |
| ICHR | ▲ Buy | Grant | 5,635 | $0 | 5/24/2022 | View on chart |
| ICHR | ▲ Buy | Option Exercise | 2,500 | $24K | 5/18/2022 | View on chart |
| ICHR | ▼ Sell | Open Market | 2,500 | $72K | 5/18/2022 | View on chart |
| ICHR | ▲ Buy | Option Exercise | 2,500 | $24K | 2/16/2022 | View on chart |
| ICHR | ▼ Sell | Open Market | 2,500 | $100K | 2/16/2022 | View on chart |
| ICHR | ▲ Buy | Option Exercise | 2,500 | $24K | 11/17/2021 | View on chart |
| ICHR | ▼ Sell | Open Market | 2,500 | $123K | 11/17/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Ichor Holdings to Report Q3 2026 Earnings on Nov 2
Ichor Holdings has scheduled its third-quarter 2026 financial results announcement for November 2nd. This upcoming report will provide investors with the latest financial data for the company. The stock is currently trading near a key support level, which may influence how the market reacts to the earnings release.
Ichor Holdings to Report Q3 2026 Earnings on Nov 2. Ichor Holdings has scheduled its third-quarter 2026 financial results announcement for November 2nd. This upcoming report will provide investors with the latest financial data for the company. The stock is currently trading near a key support level, which may influence how the market reacts to the earnings release.